Excelra Knowledge Solutions Extends License of Its Biomarker Database– GOBIOM to USFDA

HYDERABAD, India–(BUSINESS WIRE)– Excelra Knowledge Solutions today announced that it has extended its
GOBIOM (Global Online Biomarker Database) license to the Biomarker
Qualification Group of the USFDA. Excelra collaborated with the USFDA in
the year 2008 in developing the safety biomarker content in GOBIOM and
since then USFDA has been utilizing the database in its biomarker
qualification process.

GOBIOM database will assist USFDA in better understanding the impact of
clinical trial design and selection of outcomes measures, provide
information about potential, common or intersecting areas of both drug
and device developmental programs to USFDA reviewers, answer fundamental
questions regarding biomarkers during regulatory review & decision
making and help in identifying new biomarker candidates for further
consideration.

GOBIOM (Global Online Biomarker Database)

GOBIOM (Global Online Biomarker Database) is Excelra’s proprietary
repository of pre-clinical, clinical and exploratory biomarkers. It has
a collection of over 80,000 Biomarkers covering 18 therapeutic areas and
more than 1,800 therapeutic indications that have been manually
extracted from Scientific and Regulatory literatures.

Anandbir Brar, President, Excelra, said, “We are delighted to
extend our collaboration with the USFDA after starting our collaboration
back in 2008. With over 80,000 Biomarkers and more importantly the
content and coverage of the database, we hope that the utility of the
database to the NCTR and the Reviewers at the USFDA is further
maximized.”

“We are delighted that the prestigious USFDA has renewed its license.
We look forward to further collaborating with the agency and enhancing
the value of the database. Inputs from the NCTR have been invaluable in
enhancing the database since its inception in 2008,” said Dr.
Sreeni Devidas, Vice President, Business Development at Excelra.

About Excelra:

Excelra Knowledge Solutions (formerly GVK Informatics) is a leading
Informatics Solutions company that leverages its extensive scientific
knowledge base, technology and relevant domain expertise to provide
intelligent data and analytics solutions to customers globally. Its
databases on SAR (GOSTAR), Biomarkers (GOBIOM) and Clinical Outcomes are
widely used in the industry globally. Excelra’s expertise spans across
Data Solutions, Data Indexing & Abstraction and Data Analytics. The
company has over nine successful Drug Repurposing collaborations with
leading Pharmaceutical companies and has developed a proprietary Drug
Repurposing Platform and Computational Biology capabilities. Excelra has
a team of over 650 scientists with rich experience in Chemistry, Biology
and Clinical Sciences that are engaged in curation of databases spanning
SAR, Biomarkers and Clinical Outcomes. These products are considered as
Industry Standard and numerous publications have been made using the
underlying content in the databases. The portfolio of customers includes
some of the world’s largest Pharmaceutical, Biotechnology, Publishing,
Agrochemical, Life Sciences and Academic institutions in the USA, EU,
Japan and Asia Pacific.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160426005740/en/